MBL and MASP-2 concentrations in serum and MBL2 promoter polymorphisms are associated to schizophrenia

Acta Neuropsychiatrica

Volumn 24, Issue 4, 2012, Pages 199-207

  Foldager, Leslie ^a,b   Steffensen, Rudi ^c   Thiel, Steffen ^b   Als, Thomas Damm ^a,d   Nielsen, Hans Jørgen ^e   Nordentoft, Merete ^f   Mortensen, Preben Bo ^b   Mors, Ole ^a   Jensenius, Jens Christian ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^e HVIDOVRE HOSPITAL   (Denmark)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

genetics; lectin pathway; mannan binding lectin deficiency; mannan binding lectin serine protease type 2; schizophrenia

Indexed keywords

GENOMIC DNA; MANNAN BINDING LECTIN; MANNAN BINDING LECTIN 2; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE; MANNAN BINDING LECTIN ASSOCIATED SERINE PROTEINASE 2; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENZYME BLOOD LEVEL; EXON; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MENTAL PATIENT; PROMOTER REGION; PROTEIN BLOOD LEVEL; SCHIZOPHRENIA; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84864469302     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1111/j.1601-5215.2011.00618.x     Document Type: Article

References (38)

1. Yolken RH, Torrey EF., Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev 1995; 8: 131-145.
2. Eaton WW, Byrne M, Ewald H, et al., Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry 2006; 163: 521-528. (Pubitemid 44469397)
3. Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Bernstein D, Yolken RH., Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry 2001; 58: 1032-1037. (Pubitemid 33051828)
4. Yolken RH, Torrey EF., Are some cases of psychosis caused by microbial agents? A review of the evidence. Mol Psychiatry 2008; 13: 470-479. (Pubitemid 351556038)
5. Xiao JC, Buka SL, Cannon TD, et al., Serological pattern consistent with infection with type I Toxoplasma gondii in mothers and risk of psychosis among adult offspring. Microbes Infect 2009; 11: 1011-1018.
6. Håvik B, Hellard SL, Rietschel M, et al., The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia. Biol Psychiatry 2011; 70: 35-42.
7. Kraus DM, Elliott GS, Chute H, et al., CSMD1 is a novel multiple domain complement-regulatory protein highly expressed in the central nervous system and epithelial tissues. J Immunol 2006; 176: 4419-4430. (Pubitemid 44264422)
8. Stefansson H, Ophoff RA, Steinberg S, et al., Common variants conferring risk of schizophrenia. Nature 2009; 460: 744-747.
9. International Schizophrenia Consortium, Wray NR, Stone JL, et al., Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748-752.
10. Shi J, Levinson DF, Duan J, et al., Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009; 460: 753-757.
11. Thiel S, Frederiksen PD, Jensenius JC., Clinical manifestations of mannan-binding lectin deficiency. Mol Immunol 2006; 43: 86-93.
12. Mayilyan KR, Weinberger DR, Sim RB., The complement system in schizophrenia. Drug News Perspect 2008; 21: 200-210.
13. Garred P, Honore C, Ma YJ, Munthe-Fog L, Hummelshøj T., MBL2, FCN1, FCN2 and FCN3-The genes behind the initiation of the lectin pathway of complement. Mol Immunol 2009; 46: 2737-2744.
14. Garred P, Larsen F, Seyfarth J, Fujita R, Madsen HO., Mannose-binding lectin and its genetic variants. Genes Immun 2006; 7: 85-94. (Pubitemid 43336050)
15. Wing JK, Sartorius N, ÜStün TB., Diagnosis and clinical measurement in psychiatry. A reference manual for SCAN. Cambridge: Cambridge University Press, 1998.
16. World Health Organization. The ICD-10 classification of mental and behavioural disorders. Diagnostic criteria for research. Geneva: World Health Organization, 1993.
17. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. DSM-IV, 4th edn. Washington, DC: American Psychiatric Association, 1994.
18. Henckaerts L, Nielsen KR, Steffensen R, et al., Polymorphisms in innate immunity genes predispose to bacteremia and death in the medical intensive care unit. Crit Care Med 2009; 37: 192-201.
19. Mølle I, Steffensen R, Thiel S, Peterslund NA., Chemotherapy-related infections in patients with multiple myeloma: associations with mannan-binding lectin genotypes. Eur J Haematol 2006; 77: 19-26. (Pubitemid 43876201)
20. Van HE, Houtmeyers F, Massonet C, et al., Detection of single nucleotide polymorphisms in the mannose-binding lectin gene using minor groove binder-DNA probes. J Immunol Methods 2004; 287: 227-230. (Pubitemid 38510223)
21. Boldt AB, Petzl-Erler ML., A new strategy for mannose-binding lectin gene haplotyping. Hum Mutat 2002; 19: 296-306. (Pubitemid 34195192)
22. Cedzynski M, Szemraj J, Swierzko AS, et al., Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system. Clin Exp Immunol 2004; 136: 304-311. (Pubitemid 38543450)
23. Skalnikova H, Freiberger T, Chumchalova J, Grombirikova H, Sediva A., Cost-effective genotyping of human MBL2 gene mutations using multiplex PCR. J Immunol Methods 2004; 295: 139-147. (Pubitemid 41057776)
24. Boldt AB, Messias-Reason IJ, Meyer D, et al., Phylogenetic nomenclature and evolution of mannose-binding lectin (MBL2) haplotypes. BMC Genet 2010; 11: 38.
25. Olesen HV, Jensenius JC, Steffensen R, Thiel S, Schiøtz PO., The mannan-binding lectin pathway and lung disease in cystic fibrosis-dysfunction of mannan-binding lectin-associated serine protease 2 (MASP-2) may be a major modifier. Clin Immunol 2006; 121: 324-331. (Pubitemid 44738718)
26. Thiel S, Møller-Kristensen M, Jensen L, Jensenius JC., Assays for the functional activity of the mannan-binding lectin pathway of complement activation. Immunobiology 2002; 205: 446-454. (Pubitemid 35153960)
27. Møller-Kristensen M, Jensenius JC, Jensen L, et al., Levels of mannan-binding lectin-associated serine protease-2 in healthy individuals. J Immunol Methods 2003; 282: 159-167. (Pubitemid 37357041)
28. Dommett RM, Klein N, Turner MW., Mannose-binding lectin in innate immunity: past, present and future. Tissue Antigens 2006; 68: 193-209. (Pubitemid 44341793)
29. Petersen SV, Thiel S, Jensenius JC., The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 2001; 38: 133-149. (Pubitemid 32786772)
30. Browning SR, Browning BL., Rapid and accurate haplotype phasing and missing-data inference for whole-genome association studies by use of localized haplotype clustering. Am J Hum Genet 2007; 81: 1084-1097. (Pubitemid 47580259)
31. Balding DJ., A tutorial on statistical methods for population association studies. Nat Rev Genet 2006; 7: 781-791. (Pubitemid 44413222)
32. Amemiya T., Tobit models-a Survey. J Econom 1984; 24: 3-61.
33. Dudoit S, Shaffer JP, Boldrick JC., Multiple hypothesis testing in microarray experiments. Stat Sci 2003; 18: 71-103. (Pubitemid 41461823)
34. Steffensen R, Hoffmann K, Varming K., Rapid genotyping of MBL2 gene mutations using real-time PCR with fluorescent hybridisation probes. J Immunol Methods 2003; 278: 191-199. (Pubitemid 37281202)
35. Dahl M, Tybjærg-Hansen A, Schnohr P, Nordestgaard BG., A population-based study of morbidity and mortality in mannose-binding lectin deficiency. J Exp Med 2004; 199: 1391-1399. (Pubitemid 38685730)
36. Capuron L, Miller AH., Immune system to brain signaling: neuropsychopharmacological implications. Pharmacol Ther 2011; 130: 266-238.
37. Mayilyan KR, Arnold JN, Presanis JS, Soghoyan AF, Sim RB., Increased complement classical and mannan-binding lectin pathway activities in schizophrenia. Neurosci Lett 2006; 404: 336-341. (Pubitemid 44108442)
38. Sørensen R, Thiel S., Jensenius JC. Mannan-binding-lectin- associated serine proteases, characteristics and disease associations. Springer Semin Immunopathol 2005; 27: 299-319. (Pubitemid 41639883)